INOSITA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase¬4 (DPP-4) enzyme, used as an oral hypoglycemic agent
It inhibits hepatic glucose production and enhances peripheral glucose disposal thereby reducing blood-glucose concentration. It also inhibits lipolysis thereby preventing